Literature DB >> 12055128

Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246.

Bouchaïb El Bahh1, Jeffrey Q Cao, Annette G Beck-Sickinger, William F Colmers.   

Abstract

Neuropeptide Y (NPY) has been shown to suppress synaptic excitation in rat hippocampus by a presynaptic action. The Y(2) (Y(2)R) and the Y(5) (Y(5)R) receptors have both been implicated in this action. We used the non-peptide, Y(2)R-selective antagonist, BIIE0246, to test the hypothesis that the Y(2)R mediates both the presynaptic inhibitory and anti-epileptic actions of NPY in rat hippocampus in vitro. NPY and the Y(2)R-selective agonist, [ahx(5-24)]NPY, both inhibited the population excitatory postsynaptic potential (pEPSP) evoked in area CA1 by stratum radiatum stimulation in a concentration-dependent manner. BIIE0246 suppressed the inhibitory effects of both agonists, suppressing the maximal inhibition without causing a change in the agonist EC(50), in a manner inconsistent with competitive antagonism. BIIE0246 washed out from hippocampal slices extremely slowly. Application of agonist at high concentrations (1 - 3 microM) for prolonged periods did not alter the rate of washout, but did partially overcome the antagonism, inconsistent with an insurmountable antagonism by BIIE0246. In the stimulus train-induced bursting (STIB) model of ictal activity in hippocampal slices, both NPY and [ahx(5-24)]NPY inhibited primary afterdischarge (1 degrees AD) activity. BIIE0246 (100 nM) completely suppressed the actions of NPY and [ahx(5-24)]NPY in this model. In contrast, the potent Y(5)R-selective agonist, Ala(31)Aib(32)NPY, affected neither 1 degrees AD activity in the presence of BIIE0246, nor, by itself, even the pEPSP in CA1. BIIE0246 potently suppresses NPY actions in rat hippocampus, suggesting a dominant role for Y(2)R there. The apparently insurmountable antagonism observed may result from the lipophilic nature of the antagonist.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055128      PMCID: PMC1573380          DOI: 10.1038/sj.bjp.0704751

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist.

Authors:  Y Dumont; A Cadieux; H Doods; L H Pheng; R Abounader; E Hamel; D Jacques; D Regoli; R Quirion
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

2.  BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist.

Authors:  H Doods; W Gaida; H A Wieland; H Dollinger; G Schnorrenberg; F Esser; W Engel; W Eberlein; K Rudolf
Journal:  Eur J Pharmacol       Date:  1999-11-19       Impact factor: 4.432

3.  Multiple NPY receptors Inhibit GABA(A) synaptic responses of rat medial parvocellular effector neurons in the hypothalamic paraventricular nucleus.

Authors:  Nina Pronchuk; Annette G Beck-Sickinger; William F Colmers
Journal:  Endocrinology       Date:  2002-02       Impact factor: 4.736

4.  Effects of the neuropeptide Y Y(2) receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices.

Authors:  T Weiser; H A Wieland; H N Doods
Journal:  Eur J Pharmacol       Date:  2000-09-15       Impact factor: 4.432

5.  Presynaptic action of neuropeptide Y in area CA1 of the rat hippocampal slice.

Authors:  W F Colmers; K Lukowiak; Q J Pittman
Journal:  J Physiol       Date:  1987-02       Impact factor: 5.182

Review 6.  XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors.

Authors:  M C Michel; A Beck-Sickinger; H Cox; H N Doods; H Herzog; D Larhammar; R Quirion; T Schwartz; T Westfall
Journal:  Pharmacol Rev       Date:  1998-03       Impact factor: 25.468

7.  Neuropeptide Y action in the rat hippocampal slice: site and mechanism of presynaptic inhibition.

Authors:  W F Colmers; K Lukowiak; Q J Pittman
Journal:  J Neurosci       Date:  1988-10       Impact factor: 6.167

8.  The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats.

Authors:  C Cabrele; M Langer; R Bader; H A Wieland; H N Doods; O Zerbe; A G Beck-Sickinger
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

Review 9.  Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.

Authors:  C Cabrele; A G Beck-Sickinger
Journal:  J Pept Sci       Date:  2000-03       Impact factor: 1.905

10.  Neuropeptide Y reduces orthodromically evoked population spike in rat hippocampal CA1 by a possibly presynaptic mechanism.

Authors:  W F Colmers; K Lukowiak; Q J Pittman
Journal:  Brain Res       Date:  1985-11-04       Impact factor: 3.252

View more
  17 in total

1.  Overexpression of neuropeptide Y decreases responsiveness to neuropeptide Y.

Authors:  Katelynn M Corder; Qin Li; Mariana A Cortes; Aundrea F Bartley; Taylor R Davis; Lynn E Dobrunz
Journal:  Neuropeptides       Date:  2019-11-07       Impact factor: 3.286

2.  NPY2 Receptors Reduce Tonic Action Potential-Independent GABAB Currents in the Basolateral Amygdala.

Authors:  James P Mackay; Maria Bompolaki; M Regina DeJoseph; Sheldon D Michaelson; Janice H Urban; William F Colmers
Journal:  J Neurosci       Date:  2019-04-10       Impact factor: 6.167

Review 3.  Neuropeptide Y: potential role in recurrent developmental seizures.

Authors:  Celine Dubé
Journal:  Peptides       Date:  2006-12-29       Impact factor: 3.750

4.  Endogenous neuropeptide Y prevents recurrence of experimental febrile seizures by increasing seizure threshold.

Authors:  Céline Dubé; Kristen L Brunson; Mariam Eghbal-Ahmadi; Rebeca Gonzalez-Vega; Tallie Z Baram
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

5.  NPY Receptors Blockade Prevents Anticonvulsant Action of Ghrelin in the Hippocampus of Rat.

Authors:  Mina Ghahramanian Golzar; Shirin Babri; Zohre Ataie; Hadi Ebrahimi; Fariba Mirzaie; Gisou Mohaddes
Journal:  Adv Pharm Bull       Date:  2013-08-20

6.  Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo.

Authors:  S Foti; R P Haberman; R J Samulski; T J McCown
Journal:  Gene Ther       Date:  2007-08-23       Impact factor: 5.250

Review 7.  Ligands of the neuropeptide Y Y2 receptor.

Authors:  Gopi Kumar Mittapalli; Edward Roberts
Journal:  Bioorg Med Chem Lett       Date:  2013-12-04       Impact factor: 2.823

8.  Intrathecal neuropeptide Y reduces behavioral and molecular markers of inflammatory or neuropathic pain.

Authors:  A B Intondi; M N Dahlgren; M A Eilers; B K Taylor
Journal:  Pain       Date:  2007-10-31       Impact factor: 6.961

9.  Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3-L1 fibroblast cell line.

Authors:  Martin T Gericke; Joanna Kosacka; Daniela Koch; Marcin Nowicki; Thomas Schröder; Albert M Ricken; Karen Nieber; Katharina Spanel-Borowski
Journal:  Br J Pharmacol       Date:  2009-04-27       Impact factor: 8.739

10.  Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues.

Authors:  Niall P Hyland; Frida Sjöberg; Iain R Tough; Herbert Herzog; Helen M Cox
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.